AVITA Medical, Inc. (RCEL) Total Debt (2023 - 2026)

AVITA Medical (RCEL) has reported Total Debt for 4 consecutive years, with $46.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt rose 3.19% year-over-year to $46.7 million; the trailing twelve-month figure through Jun 2026 stood at $46.7 million (up 3.19% YoY), and the FY2025 full-year result was $43.0 million, up 1.75% from the prior year.
• Total Debt rose to $46.7 million in Q2 2026 per RCEL's latest filing, from $43.0 million in the prior quarter.
• Across five years, Total Debt topped out at $46.7 million in Q2 2026 and bottomed at $39.8 million in Q4 2023.
• Historically, Total Debt has averaged $42.9 million across 4 years, with a median of $42.5 million in 2024.
• The widest YoY moves for Total Debt: up 10.31% in 2025, down 0.23% in 2025.
• Over 4 years, Total Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then gained by 1.75% to $43.0 million in 2025, then climbed by 8.55% to $46.7 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $46.7 million, $43.0 million, and $42.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.